News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Rolls Pulsar Vascular and Neuravi Acquisitions Into a New Neurovascular Biz Dubbed Cerenovus



7/25/2017 7:22:29 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions into a new neurovascular business dubbed Cerenovus.

The New Brunswick, N.J.-based healthcare giant said the new brand, unveiled at the annual meeting of the Society of NeuroInterventional Surgery in Colorado Springs, is derived from the Latin words for ‘new’ and ‘brain’ and will focus on hemorrhagic and ischemic stroke.

“Our neurovascular business is evolving and Cerenovus reflects our bold new vision, positioning and priorities,” group chairman Shlomi Nachman said in prepared remarks. “Inspired by how quickly a stroke can affect a person’s mind and our commitment to reducing the devastating impact, Cerenovus aims to help physicians give stroke patients a new lease on life.”

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES